Description
| What It Is | Tesamorelin is a stabilized synthetic analogue of growth hormone–releasing hormone (GHRH 1–44) studied in laboratory research as a ligand for the growth hormone–releasing hormone receptor (GHRHR). |
| What It’s Derived From | Tesamorelin is derived from the endogenous 44–amino–acid GHRH sequence and incorporates a trans-3-hexenoic acid modification to enhance peptide stability and receptor-binding characteristics in experimental systems. |
| What Research Focuses On | Research evaluates Tesamorelin in in vitro and preclinical models examining GHRHR activation, receptor-binding kinetics, downstream cAMP-mediated signaling pathways, somatotropic axis modulation, and GH/IGF-associated molecular readouts under controlled laboratory conditions. |





Reviews
There are no reviews yet.